Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol

INTRODUCTION: Immune thrombocytopaenia (ITP) is an acquired disorder of low platelets and risk of bleeding. Although many children can be observed until spontaneous remission, others require treatment due to bleeding or impact on health-related quality of life. Standard first-line therapies for thos...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimano, Kristin A, Grace, Rachael F, Despotovic, Jenny M, Neufeld, Ellis J, Klaassen, Robert J, Bennett, Carolyn M, Ma, Clement, London, Wendy B, Neunert, Cindy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Haematology (Incl Blood Transfusion)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404450/
https://www.ncbi.nlm.nih.gov/pubmed/34452956
http://dx.doi.org/10.1136/bmjopen-2020-044885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404450/
https://www.ncbi.nlm.nih.gov/pubmed/34452956
http://dx.doi.org/10.1136/bmjopen-2020-044885

Ejemplares similares